Home » Business, Health & Medicine, Manufacturing & Industry, Marketing & Sales, Pharmaceuticals & Biotech » Global Computational Biology Market is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%: Hexa Reports
Hexa Reports Provide – The application of “Computational Biology” in proteomics for cellular simulation is expected to grow at the fastest CAGR of over 22% owing to the shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of development of personalized medicine.

The global market for computational biology is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%. Steady increase in the usage & application of computational biology for bioinformatics R&D programs designed for sequencing genomes to better understand biological systems and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug discovery studies are expected to drive computational biology demand over the next six years.

Computational genomics for cellular and biological simulation applications dominated the market in 2013, accounting for over 47% of global revenue. Key factors driving demand for these applications include the growth of drug designing, disease modeling and personalized medicine applications and the growing usage of computational biology for functional and structural genomics, epigenomics and metagenomics for the analysis of protein transcription, protein-protein interactions, gene sequencing and expression and 3-dimensional protein structure analysis.

Browse Detailed Report with TOC at:
http://www.hexareports.com/report/computational-biology-market/details

Further key findings from the study suggest:

North America was the largest regional market, accounting for 58.0% of the global revenue in 2013. Its large share is majorly attributed to the growing research investments and initiatives for development of drug discovery, disease modeling technologies and innovations in biological computation methods. It is expected that Asia Pacific will witness the fastest growth in the market, at an estimated CAGR of 28.0% owing to the increasing expenditure in clinical studies for pharmacokinetics and pharmacogenomics.

The application of computational biology in proteomics for cellular simulation is expected to grow at the fastest CAGR of over 22% owing to the shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of development of personalized medicine.

Drug discovery and disease modelling applications dominated the market, accounting for 58.0% of global revenue in 2013. This large share is attributed by the extensive drug development pipelines present for a number of global branded and generic drug manufacturing firms such as Sanofi, Novo Nordisk and Eli Lilly.

Computational Biology databases dominated the tools segment and accounted for 44.5% of the market revenue in 2013, owing to extensive genomic database usage for warehousing and data mining of biological and sequential data generated from genomic and proteomic studies. Consequentially, the software and services for the analysis of biological data is expected to witness the fastest CAGR of over 21.0%.

Key players of this market include Schrodinger, Accelrys, Certara, Entelos, Simulation Plus and others.

Browse “Healthcare” Related Report:

China Automatic coagulation analyzer Industry 2015:
http://www.hexareports.com/report/china-automatic-coagulation-analyzer-industry

Top ICT spenders in the Australian Healthcare Sector:
http://www.hexareports.com/report/top-ict-spenders-in-the-australian-healthcare-sector

The mHealth (Mobile Healthcare) Ecosystem:
http://www.hexareports.com/report/the-mhealth-mobile-healthcare-ecosystem-2015-2030-opportunities-challenges-strategies-forecasts


For the purpose of this study, Grand View Research has segmented the computational biology market on the basis of applications, tools, services, end users and region:

Computational Biology Application Outlook
Cellular & Biological Simulation
Computational Genomics
Computational Proteomics
Pharmacogenomics
Others (Transcriptomics/Metabolomics)

Drug Discovery and Disease Modelling
Target Identification
Target Validation
Lead Discovery
Lead Optimization
Preclinical Drug Development
Pharmacokinetics
Pharmacodynamics

Clinical trials
Phase I
Phase II
Phase III

Request a Sample of “Computational Biology Market” Report at:
http://www.hexareports.com/sample/42483


About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Media Contact
Company Name: Hexa Reports
Contact Person: Ryan Shaw
Email: sales@hexareports.com
Phone: 1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States
Website: http://www.hexareports.com/report/computational-biology-market/details

Comments are closed.